Price: FREE to College members, $25 non-members

COVID-19 is taking a toll on the financial health of many allergy/immunology practices. New patient, allergy shot and skin testing volumes are down substantially in some practices, which is directly impacting practice cashflow. In this town hall discussion our experts review options allergists can take to stabilize their practices. Topics include analyzing your financial position, loan options (including the new government SBA loans and Medicare loans), and managing expenses.

Disclaimer

This webcast is provided for general information purposes only and does not constitute accounting, legal, tax, or other professional advice. It is the opinion of the speakers only. They provide content they believe is true and accurate as of the date of the webcast; however, they give no assurance or warranty regarding the accuracy, timeliness, or applicability of any of the contents. 

We’d also like to clarify one point. During the webinar, there was mention of possible ALK allergen immunotherapy extract shortage. The College checked with ALK and they assured us that there is NO U.S. shortage of allergen immunotherapy extract. 

The American College of Allergy, Asthma, and Immunology accepts no responsibility for information presented during this webcast and disclaims all liability in respect of such information, including but not limited to any liability for errors, inaccuracies, omissions, or misleading or defamatory statements. You should not act upon the content or information in this webcast without first seeking appropriate advice from an accountant, lawyer or other professional.